Advisory Services Network, LLC Mannkind Corp Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$3.34 - $4.29 $3,340 - $4,290	1,000 New	1,000 $3,000
Q4 2020 Feb 09, 2021	SELL	$1.79 - $4.04 $3,580 - $8,080	-2,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.56 - $2.08 $3,120 - $4,160	2,000 New	2,000 $4,000
Q2 2020 Aug 10, 2020	SELL	$0.94 - $2.21 $1,880 - $4,420	-2,000 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$1.14 - $1.49 $2,188 - $2,860	1,920 Added 2400.0%	2,000 $3,000
Q4 2018 Feb 15, 2019	SELL	$1.02 - $2.05 $7,140 - $14,349	-7,000 Reduced 98.87%	80 $0
Q3 2018 Nov 02, 2018	BUY	$1.01 - $2.19 $3,110 - $6,745	3,080 Added 77.0%	7,080 $13,000
Q1 2018 Apr 23, 2018	BUY	$2.28 - $3.8 $9,120 - $15,200	4,000 New	4,000 $0

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.81B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.